Navigation Links
Global Markets and Technologies for Molecular Imaging Devices
Date:9/2/2014

EVENUE BY DEVICE IN ITALY, 2013 AND 2018 ($
MILLIONS) 166
SPAIN 167
TABLE 84 MARKET FOR MOLECULAR IMAGING DEVICES IN SPAIN, THROUGH 2018
($ MILLIONS/UNITS) 167
FIGURE 36 MARKET FOR MOLECULAR IMAGING DEVICES IN SPAIN, 2012-2018 ($
MILLIONS) 167
TABLE 85 MOLECULAR IMAGING REVENUE BY DEVICE TYPE IN SPAIN, THROUGH
2018 ($ MILLIONS) 168
FIGURE 37 MOLECULAR IMAGING REVENUE BY DEVICE TYPE IN SPAIN, 2013-2018
($ MILLIONS) 168
UNITED KINGDOM 169
TABLE 86 MARKET FOR MOLECULAR IMAGING DEVICES IN THE U.K., THROUGH
2018 ($ MILLIONS/UNITS) 169
FIGURE 38 MARKET FOR MOLECULAR IMAGING DEVICES IN THE U.K., 2012-2018 ($
MILLIONS) 169
TABLE 87 MOLECULAR IMAGING REVENUE BY DEVICE IN THE U.K., 2013 AND 2018
($ MILLIONS) 170
FIGURE 39 MOLECULAR IMAGING REVENUE BY DEVICE IN THE U.K., 2013 AND
2018 ($ MILLIONS) 170
SCANDINAVIA 171
TABLE 88 MARKET FOR MOLECULAR IMAGING DEVICES IN THE SCANDINAVIA
REGION, THROUGH 2018 ($ MILLIONS/UNITS) 171
FIGURE 40 MARKET FOR MOLECULAR IMAGING DEVICES IN THE SCANDINAVIA
REGION, 2012-2018 ($ MILLIONS) 171
TABLE 89 MOLECULAR IMAGING REVENUE BY DEVICE IN THE SCANDINAVIA
REGION, 2013 AND 2018 ($ MILLIONS) 172
FIGURE 41 MOLECULAR IMAGING REVENUE BY DEVICE IN THE SCANDINAVIA
REGION, 2013-2018 ($ MILLIONS) 172
BENELUX 173
TABLE 90 MARKET FOR MOLECULAR IMAGING DEVICES IN THE BENELUX REGION,
THROUGH 2018 ($ MILLIONS/UNITS) 173
FIGURE 42 MARKET FOR MOLECULAR IMAGING DEVICES IN THE BENELUX REGION,
2012-2018 ($ MILLIONS) 173
TABLE 91 MOLECULAR IMAGING REVENUE BY DEVICE IN THE BENELUX REGION,
2013 AND 2018 ($ MILLIONS) 175
FIGURE 43 MOLECULAR IMAGING REVENUE BY DEVICE IN THE BENELUX REGION,
2013 AND 2018 ($ MILLIONS) 175

CHAPTER 11 THE AS
'/>"/>
SOURCE ReportBuyer
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine technology :

1. Bariatric Surgery: Global Markets for Services and Devices
2. Acute Heart Failure Global Clinical Trials Review, H2, 2014
3. Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden
4. Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke
5. Avanir Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference
6. Abaxis, Inc. to Present at the Morgan Stanley Global Healthcare Conference
7. Hologic to Present at the Morgan Stanley Global Healthcare Conference
8. Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th
9. Veracyte to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2014
10. CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz
11. Contract Research Organization WCCT Global Celebrates Being Named as One of the Fastest Growing Companies in America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 30, 2015  Today we bring you a special edition of #MedicareMonday on Medicare,s ... about some of our Medicare resources and continue highlighting the success of the prescription ... Check out our latest infographics and videos here: http://onphr.ma/1INp9qQ ... ... ...
(Date:7/30/2015)... 30, 2015  Amgen (NASDAQ: AMGN ) ... of 2015. Key results include: , Total ... of 2014 to $5,370 million, with 6 percent ... (etanercept), Prolia ® (denosumab), Sensipar ® ... ® (denosumab). Unfavorable changes in foreign exchange ...
(Date:7/30/2015)... CHENGDU, China , July 30, 2015 ... "Company"), a pharmaceutical company that specializes in the patented ... active pharmaceutical ingredients (API), provided updates regarding the notice ... MKT LLC (the "Exchange") indicating that the Company was ... set forth in Sections 134 and 1101 of the ...
Breaking Medicine Technology:Happy 50th Anniversary Medicare! 2Happy 50th Anniversary Medicare! 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2
... the "NEXT" Study Also Showed Arzoxifene Significantly Suppressed ... with OsteoporosisATHENS, Greece, March 23 Eli Lilly ... new data showing arzoxifene, an investigational selective estrogen ... increasing bone mineral density (BMD) in the lumbar ...
... Santaris Pharma announced today that,the fourth LNA-based drug ... USA,several patients with cancer have now been treated ... by Santaris Pharma and Enzon,Pharmaceuticals. The U.S. Food ... New Drug (IND) application,for the use of the ...
Cached Medicine Technology:Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 2Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 3Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 4Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 5Another LNA-based RNA Inhibitor Enters Clinical Trials 2Another LNA-based RNA Inhibitor Enters Clinical Trials 3
(Date:7/31/2015)... ... , ... Super Bowl 50 will emanate from Levi’s Stadium in Santa Clara, CA ... the Super Bowl. In the two weeks that separate the conference championships and the Super ... Super Bowl game will mark the 50th time it has been held and the festivities ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... industry players to know in predictive health analytics , Jvion continues to ... The firm creates predictive software that targets patient and population level illness to ...
(Date:7/31/2015)... ... ... Sculpted Contours Luxury Medical Aesthetics announces the arrival of the newest applicator ... new applicator in the United States as an upgrade to the CoolSmooth applicator cleared ... applicator required a 2 hour treatment time. The new CoolSmooth Pro reduces the ...
(Date:7/31/2015)... ... July 31, 2015 , ... Facebook, ... Inc. has re-branded their social media profiles to better connect with the public. ... to communicate, find information, share insights and opinions. The Rally Insurance Group, Inc.’s ...
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reliable ... looking to catch a new and refreshing show on Broadway, look no further than ... including an Obie Award, Outer Critics Circle Award, Drama Desk Award, Lucille Lortel Award, ...
Breaking Medicine News(10 mins):Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 4Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 5Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 6Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 7
... a five-month-old baby boy will undergo a liver transplant at the ... forward.// The surgery is expected to take as long as 10 ... be used. ,Lennox developed chronic liver problems and ... to be completely blocked, and a transplant appeared to be the ...
... that go the wrong way to cause cancer were to form ... first page.// ,The U.S. government has set out to ... makeup of cancer, with the idea of speeding the discovery of ... luck. ,Dr. Francis Collins, the National Institutes of Health's ...
... There has been a considerable fall in the donations towards ... the United Nations (UN). The December 2005 contributions were not ... // ,Jan Vandemoortele, the UN Resident Coordinator has appealed ... been pledged by them. A special envoy will be appointed ...
... bird flu, increasing the risk of human infection in parts ... from a 35-year-old man who died in Jakarta last month ... World Health Organization reference laboratory, Health Ministry officials said today. ... bird flu in the world's fourth most-populous nation to 9. ...
... new pathway with regard to the progression of chronic myelogenous ... They have also found out that an extract from the ... used for suppressing the process. As many as 4,600 people ... year, and the findings may contribute towards their treatment options. ...
... been lots of talk about the health benefits of nuts but ... pack a nutritional wallop — at least when eaten in moderation.// ... for most nuts to say that there is good evidence they ... study it has been found that a diet rich in fruits ...
Cached Medicine News:Health News:U.S. launching cancer gene-mapping pilot 2Health News:Indonesia Has Ninth Bird-Flu Death as Risk Mounts 2
Primary knee system, symmetrical in design....
Cruciate retaining, posterior stabilized and constrained components....
Maximum contact. Minimum wear. Outstanding results....
...
Medicine Products: